Literature DB >> 20708383

Fatal status epilepticus: a clinico-pathological analysis among 100 patients: from a developing country perspective.

Sanjib Sinha1, Parthasarathy Satishchandra, Anita Mahadevan, Bipin C Bhimani, Jerry M E Kovur, Susarla K Shankar.   

Abstract

PURPOSE: We evaluated the neuropathological features associated with fatal SE with emphasis on neuroanatomy and etiology, and attempted to correlate with the clinical observations.
MATERIALS AND METHODS: Details of 100 (n=100; M:F=64:36) autopsied cases of status epilepticus were studied retrospectively with emphasis on clinico-pathological characteristics.
RESULTS: Sixty-five percent of patients presented for the first time as SE. Patients with prior history of epilepsy (35%), had discontinued treatment in 71.4% of cases, resulting in SE. Majority of patients with SE had generalized convulsive seizures (75%). The mean GCS score at admission was 4.4. Median delay in initiating the treatment following seizure was 23.5h (mean: 29.5±32.8h). The etiological factors could be identified in two-thirds of cases, neuroinfection (n=34) and stroke (n=16) being the commonest. Frontal lobe was the most commonly involved area (38.6%), in both localized and multilobar pathology. Dual pathology was observed in seven patients. Clinico-pathological concordance was noted in 58%. The discordance observed in 42 patients was either due to low index of suspicion for additional etiologies, inaccurate neuroimaging interpretation or non-availability of extensive diagnostic modalities prior to referring to this centre.
CONCLUSIONS: This is one of the largest cohort of fatal SE with pathological correlation in the literature. Clinico-pathological concordance was observed in 58% of patients. Neuroinfection and cerebral stroke were observed in two-thirds of patients as the etiological factor. Prolonged duration of SE, long delay in initiating treatment, poor GCS score at admission, poor drug compliance and symptomatic etiologies were common in this cohort of fatal SE from a developing country, most of which could have been preventable.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20708383     DOI: 10.1016/j.eplepsyres.2010.07.012

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  7 in total

Review 1.  Epilepsy in India I: Epidemiology and public health.

Authors:  Senthil Amudhan; Gopalkrishna Gururaj; Parthasarathy Satishchandra
Journal:  Ann Indian Acad Neurol       Date:  2015 Jul-Sep       Impact factor: 1.383

2.  Epilepsy: Indian perspective.

Authors:  Nandanavana Subbareddy Santhosh; Sanjib Sinha; Parthasarathy Satishchandra
Journal:  Ann Indian Acad Neurol       Date:  2014-03       Impact factor: 1.383

3.  Extensive cortical diffusion restriction in a 50-year-old female with hyperammonemic encephalopathy and status epilepticus.

Authors:  Adam de Havenon; Kris French; Safdar Ansari
Journal:  Case Rep Neurol Med       Date:  2014-04-24

Review 4.  Review on Epileptic Seizure Prediction: Machine Learning and Deep Learning Approaches.

Authors:  Milind Natu; Mrinal Bachute; Shilpa Gite; Ketan Kotecha; Ankit Vidyarthi
Journal:  Comput Math Methods Med       Date:  2022-01-20       Impact factor: 2.238

5.  Need for a national epilepsy control program.

Authors:  M Tripathi; D C Jain; M Gourie Devi; S Jain; V Saxena; P S Chandra; K Radhakrishnan; M Behari; M Gupta; V Puri; M M Mehndiratta; K Bala; K S Anand; S Rawat; P U Shah; S Gulati; S Johri; V V Nadkarni; P Sarat Chandra; D Bachani
Journal:  Ann Indian Acad Neurol       Date:  2012-04       Impact factor: 1.383

6.  Treatment of recurrent epileptic seizures in patients with neurological disorders.

Authors:  Guan-Qian Yuan; Dan-Dan Gao; Jun Lin; Song Han; Bo-Chuang Lv
Journal:  Exp Ther Med       Date:  2012-11-01       Impact factor: 2.447

7.  A Comparative Study of Midazolam and Target-Controlled Propofol Infusion in the Treatment of Refractory Status Epilepticus.

Authors:  Dheeraj Masapu; K N Gopala Krishna; Sinha Sanjib; Dhrithiman Chakrabarti; R C Mundlamuri; Nitin Manohar; P Mariamma; P Satishchandra; G S Umamaheswara Rao
Journal:  Indian J Crit Care Med       Date:  2018-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.